Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ZLAB
    4. >
  4. Valuation

Valuation

-
stocks logo
ZLAB
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is ZLAB Overvalued？

ZLAB is now in the zone, suggesting that ZLAB current forward PE ratio of -15.70 is considered compare with the five-year average of -12.73.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

ZLAB Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
ZLAB.O
Zai Lab Ltd
loss
Average P/E: 17.91
19.13%
37.69B
stocks logo
BNTX.O
Biontech SE
loss
Average P/E: 17.91
20.90%
26.08B
stocks logo
SMMT.O
Summit Therapeutics Inc
loss
Average P/E: 17.91
-153.97%
13.64B
stocks logo
ILMN.O
Illumina Inc
19.81
Average P/E: 17.91
206.19%
14.09B
stocks logo
MRNA.O
Moderna Inc
loss
Average P/E: 17.91
12.00B
stocks logo
BMRN.O
Biomarin Pharmaceutical Inc
16.01
Average P/E: 17.91
487.96%
13.19B

ZLAB Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

ZLAB FAQs

Is ZLAB currently overvalued based on its P/E ratio?

According to the provided data, ZLAB's 5-year historical average forward P/E ratio is -12.73. ZLAB forward P/E ratio is -15.70, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for ZLAB?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has ZLAB's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 6.62 to 6.49, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for ZLAB's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

ZLAB PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
-12.73
Current PE
-15.70
Overvalued PE
-3.26
Undervalued PE
-22.20

ZLAB EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
-10.51
Current EV
-14.49
Overvalued EV
-2.58
Undervalued EV
-18.45

ZLAB P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
27.27
Current PS
7.52
Overvalued PS
58.39
Undervalued PS
-3.85

ZLAB Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
ZLAB.O
Zai Lab Ltd
loss
Average P/E: 17.91
19.13%
37.69B
stocks logo
BNTX.O
Biontech SE
loss
Average P/E: 17.91
20.90%
26.08B
stocks logo
SMMT.O
Summit Therapeutics Inc
loss
Average P/E: 17.91
-153.97%
13.64B
stocks logo
ILMN.O
Illumina Inc
19.81
Average P/E: 17.91
206.19%
14.09B
stocks logo
MRNA.O
Moderna Inc
loss
Average P/E: 17.91
12.00B
stocks logo
BMRN.O
Biomarin Pharmaceutical Inc
16.01
Average P/E: 17.91
487.96%
13.19B

ZLAB Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is ZLAB undervalued？Is ZLAB overvalued compared to its competitors？

ZLAB FAQs

Is ZLAB currently overvalued based on its P/E ratio?

According to the provided data, ZLAB's 5-year historical average forward P/E ratio is -12.73. ZLAB forward P/E ratio is -15.70, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for ZLAB?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has ZLAB's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 6.62 to 6.49, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for ZLAB's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is ZLAB undervalued？Is ZLAB overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free